Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 266

1.

Multiplexed Fc array for evaluation of antigen-specific antibody effector profiles.

Brown EP, Dowell KG, Boesch AW, Normandin E, Mahan AE, Chu T, Barouch DH, Bailey-Kellogg C, Alter G, Ackerman ME.

J Immunol Methods. 2017 Apr;443:33-44. doi: 10.1016/j.jim.2017.01.010. Epub 2017 Feb 3.

2.

Complex immune correlates of protection in HIV-1 vaccine efficacy trials.

Tomaras GD, Plotkin SA.

Immunol Rev. 2017 Jan;275(1):245-261. doi: 10.1111/imr.12514. Review.

PMID:
28133811
3.

Polyvalent vaccine approaches to combat HIV-1 diversity.

Korber B, Hraber P, Wagh K, Hahn BH.

Immunol Rev. 2017 Jan;275(1):230-244. doi: 10.1111/imr.12516. Review.

PMID:
28133800
4.

In silico comparison of Iranian HIV -1 envelop glycoprotein with five nearby countries.

Ghafari M, Behbahani M, Mohabatkar H.

Mol Biol Res Commun. 2016 Jun;5(2):114-121.

5.

Sensitive Next-Generation Sequencing Method Reveals Deep Genetic Diversity of HIV-1 in the Democratic Republic of the Congo.

Rodgers MA, Wilkinson E, Vallari A, McArthur C, Sthreshley L, Brennan CA, Cloherty G, de Oliveira T.

J Virol. 2017 Feb 28;91(6). pii: e01841-16. doi: 10.1128/JVI.01841-16. Print 2017 Mar 15.

6.

Increased frequencies of CD8+CD57+ T cells are associated with antibody neutralization breadth against HIV in viraemic controllers.

Palmer CD, Romero-Tejeda M, Scully EP, Lockhart A, Seaman MS, Goldenthal A, Piechocka-Trocha A, Walker BD, Chibnik LB, Jost S, Porichis F.

J Int AIDS Soc. 2016 Dec 9;19(1):21136. doi: 10.7448/IAS.19.1.21136. eCollection 2016.

7.

Diversification in the HIV-1 Envelope Hyper-variable Domains V2, V4, and V5 and Higher Probability of Transmitted/Founder Envelope Glycosylation Favor the Development of Heterologous Neutralization Breadth.

Smith SA, Burton SL, Kilembe W, Lakhi S, Karita E, Price M, Allen S, Hunter E, Derdeyn CA.

PLoS Pathog. 2016 Nov 16;12(11):e1005989. doi: 10.1371/journal.ppat.1005989. eCollection 2016 Nov.

8.

Deconstructing the Antiviral Neutralizing-Antibody Response: Implications for Vaccine Development and Immunity.

VanBlargan LA, Goo L, Pierson TC.

Microbiol Mol Biol Rev. 2016 Oct 26;80(4):989-1010. Print 2016 Dec. Review.

PMID:
27784796
9.

Epigraph: A Vaccine Design Tool Applied to an HIV Therapeutic Vaccine and a Pan-Filovirus Vaccine.

Theiler J, Yoon H, Yusim K, Picker LJ, Fruh K, Korber B.

Sci Rep. 2016 Oct 5;6:33987. doi: 10.1038/srep33987.

10.

Sequential Immunization with gp140 Boosts Immune Responses Primed by Modified Vaccinia Ankara or DNA in HIV-Uninfected South African Participants.

Churchyard G, Mlisana K, Karuna S, Williamson AL, Williamson C, Morris L, Tomaras GD, De Rosa SC, Gilbert PB, Gu N, Yu C, Mkhize NN, Hermanus T, Allen M, Pensiero M, Barnett SW, Gray G, Bekker LG, Montefiori DC, Kublin J, Corey L.

PLoS One. 2016 Sep 1;11(9):e0161753. doi: 10.1371/journal.pone.0161753. eCollection 2016.

11.

Association of lymph-node antigens with lower Gag-specific central-memory and higher Env-specific effector-memory CD8(+) T-cell frequencies in a macaque AIDS model.

Ishii H, Matsuoka S, Nomura T, Nakamura M, Shiino T, Sato Y, Iwata-Yoshikawa N, Hasegawa H, Mizuta K, Sakawaki H, Miura T, Koyanagi Y, Naruse TK, Kimura A, Matano T.

Sci Rep. 2016 Jul 25;6:30153. doi: 10.1038/srep30153.

12.

Ancestral Reconstruction.

Joy JB, Liang RH, McCloskey RM, Nguyen T, Poon AF.

PLoS Comput Biol. 2016 Jul 12;12(7):e1004763. doi: 10.1371/journal.pcbi.1004763. eCollection 2016 Jul. No abstract available.

13.

The thermostability and specificity of ancient proteins.

Wheeler LC, Lim SA, Marqusee S, Harms MJ.

Curr Opin Struct Biol. 2016 Jun;38:37-43. doi: 10.1016/j.sbi.2016.05.015. Epub 2016 Jun 9. Review.

PMID:
27288744
14.

A Multi-Component Prime-Boost Vaccination Regimen with a Consensus MOMP Antigen Enhances Chlamydia trachomatis Clearance.

Badamchi-Zadeh A, McKay PF, Korber BT, Barinaga G, Walters AA, Nunes A, Gomes JP, Follmann F, Tregoning JS, Shattock RJ.

Front Immunol. 2016 Apr 28;7:162. doi: 10.3389/fimmu.2016.00162. eCollection 2016.

15.

Targeting HIV-1 Env gp140 to LOX-1 Elicits Immune Responses in Rhesus Macaques.

Zurawski G, Zurawski S, Flamar AL, Richert L, Wagner R, Tomaras GD, Montefiori DC, Roederer M, Ferrari G, Lacabaratz C, Bonnabau H, Klucar P, Wang Z, Foulds KE, Kao SF, Yates NL, LaBranche C, Jacobs BL, Kibler K, Asbach B, Kliche A, Salazar A, Reed S, Self S, Gottardo R, Galmin L, Weiss D, Cristillo A, Thiebaut R, Pantaleo G, Levy Y.

PLoS One. 2016 Apr 14;11(4):e0153484. doi: 10.1371/journal.pone.0153484. eCollection 2016.

16.

Modular synthesis of N-glycans and arrays for the hetero-ligand binding analysis of HIV antibodies.

Shivatare SS, Chang SH, Tsai TI, Tseng SY, Shivatare VS, Lin YS, Cheng YY, Ren CT, Lee CC, Pawar S, Tsai CS, Shih HW, Zeng YF, Liang CH, Kwong PD, Burton DR, Wu CY, Wong CH.

Nat Chem. 2016 Apr;8(4):338-46. doi: 10.1038/nchem.2463. Epub 2016 Mar 7.

17.

Potential To Streamline Heterologous DNA Prime and NYVAC/Protein Boost HIV Vaccine Regimens in Rhesus Macaques by Employing Improved Antigens.

Asbach B, Kliche A, Köstler J, Perdiguero B, Esteban M, Jacobs BL, Montefiori DC, LaBranche CC, Yates NL, Tomaras GD, Ferrari G, Foulds KE, Roederer M, Landucci G, Forthal DN, Seaman MS, Hawkins N, Self SG, Sato A, Gottardo R, Phogat S, Tartaglia J, Barnett SW, Burke B, Cristillo AD, Weiss DE, Francis J, Galmin L, Ding S, Heeney JL, Pantaleo G, Wagner R.

J Virol. 2016 Mar 28;90(8):4133-49. doi: 10.1128/JVI.03135-15. Print 2016 Apr.

18.

Distinct genital tract HIV-specific antibody profiles associated with tenofovir gel.

Archary D, Seaton KE, Passmore JS, Werner L, Deal A, Dunphy LJ, Arnold KB, Yates NL, Lauffenburger DA, Bergin P, Liebenberg LJ, Samsunder N, Mureithi MW, Altfeld M, Garrett N, Abdool Karim Q, Abdool Karim SS, Morris L, Tomaras GD.

Mucosal Immunol. 2016 May;9(3):821-33. doi: 10.1038/mi.2015.145. Epub 2016 Jan 27.

19.

Novel Conserved-region T-cell Mosaic Vaccine With High Global HIV-1 Coverage Is Recognized by Protective Responses in Untreated Infection.

Ondondo B, Murakoshi H, Clutton G, Abdul-Jawad S, Wee EG, Gatanaga H, Oka S, McMichael AJ, Takiguchi M, Korber B, Hanke T.

Mol Ther. 2016 Apr;24(4):832-42. doi: 10.1038/mt.2016.3. Epub 2016 Jan 8.

20.

Monitoring HIV-1 Group M Subtypes in Yaoundé, Cameroon Reveals Broad Genetic Diversity and a Novel CRF02_AG/F2 Infection.

Courtney CR, Agyingi L, Fokou A, Christie S, Asaah B, Meli J, Ngai J, Hewlett I, Nyambi PN.

AIDS Res Hum Retroviruses. 2016 Apr;32(4):381-5. doi: 10.1089/aid.2015.0286. Epub 2015 Dec 17.

Supplemental Content

Support Center